Skip to content

The Effect of Massage on Serum Bilirubin Levels in Term Neonates

The Effect of Massage on Serum Bilirubin Levels in Term Neonates ffected with Hyperbilirubinemia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138811043150N1
Enrollment
25
Registered
2011-05-09
Start date
2009-05-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbilirubinemia. Neonatal jaundice, unspecified

Interventions

Intervention 1: intervention groups: tactile and kinesthetic stimulation will carry out by the mother under the supervision of the researcher in 15-minute sessions in 3 consecutive hours, daily for 4
Treatment - Other
intervention groups: tactile and kinesthetic stimulation will carry out by the mother under the supervision of the researcher in 15-minute sessions in 3 consecutive hours, daily for 4 days. Each sessi
control group will administer routine ward care.

Sponsors

Vice chancellor for research, Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 7 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: term neonates born after 37-42 weeks of pregnancy; weighing between 2500gm and 4000gm; having a bilirubin level of 13–24mg/dl; All the children were breast fed; were not under any medication and showed no contra-indications to massage. Exclusion criteria: having jaundice on the 1st day of birth; hyper bilirubinemia caused by hemolysis; diseases or infections occurring in the course of the study; blood transfusion carried out in the infant; the occurrence of bronze children's syndrome during phototherapy; diarrhea during phototherapy; and lastly the desire of the parents to be omitted from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Level of Serum Bilirubin. Timepoint: Daily. Method of measurement: Blood test.

Secondary

MeasureTime frame
Jaundice. Timepoint: End study. Method of measurement: Clinical Sign.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Basiri Moqadam

Gonabad University of Medical Sciences

Basiri1344@gmu.ac.ir+98 53 3733 2629

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026